JENA, Germany—Bronwyn Brophy O'Connor has been named the new CEO of Carl Zeiss Meditec AG, Zeiss Group has announced. She has also been named as the new executive board member of Carl Zeiss AG responsible for the Medical Technology segment. In this role, O’Connor, who presently serves as CEO of the NASDAQ Stockholm-listed Vitrolife Group (VITR.ST), a global med-tech company in Sweden, will succeed Andreas Pecher, who, in addition to his primary role as president and CEO of Carl Zeiss AG, has served as CEO of Carl Zeiss Meditec AG on an interim basis since January 1, 2026.